Welcome to our dedicated page for Sunopta SEC filings (Ticker: STKL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Looking for the numbers behind SunOpta’s oat-milk boom? Investors typically start with the SunOpta annual report 10-K simplified or ask, “How do I track SunOpta insider trading Form 4 transactions in real time?” This page answers those questions in one place, collecting every SEC disclosure so you can study ingredient cost swings, capacity expansions, and sustainability commitments without wading through EDGAR.
Our platform layers AI-powered summaries over each document to turn legal language into plain English. Whether you need a quick take on a SunOpta quarterly earnings report 10-Q filing, an alert for a sudden SunOpta 8-K material events explained, or context around a SunOpta proxy statement executive compensation table, the insights arrive within seconds of posting. Form 4 data is refreshed continuously, so SunOpta Form 4 insider transactions real-time and “SunOpta executive stock transactions Form 4” appear the moment insiders buy or sell.
- Instant answers for “understanding SunOpta SEC documents with AI”
- Side-by-side SunOpta earnings report filing analysis across quarters
- Historical archive of every filing type—10-K, 10-Q, 8-K, 3, 4, 13D, S-1 and more
Because SunOpta controls sourcing, processing, and packaging, its filings contain unique disclosures on organic crop pricing, aseptic-line capital spending, and customer concentration in private-label contracts. Our expert analysis highlights those details, so you can compare segment margins, monitor insider buying before new beverage launches, or model cash flows—all without scrolling through hundreds of pages. Complex documents made clear, delivered the moment they’re filed.
Robert Duchscher, Chief Information Officer of SunOpta Inc. (STKL), reported an insider transaction on Form 4. The filing shows a sale of 47,500 common shares on 08/11/2025 at a weighted-average price of $6.2204. Following the reported transaction, the reporting person directly beneficially owned 11,322 shares. The Form 4 was signed by an attorney-in-fact, Chris McCullough, on 08/12/2025.
A footnote states the reported price is a weighted average and that purchases were made at prices ranging from $6.0900 to $6.2950; the reporting person offers to provide a breakdown of the number of shares sold at each price upon request.
SunOpta, Inc. (STKL) filed a Form 144 reporting a proposed sale of 47,500 common shares with an aggregate market value of $295,469. The filing lists the sale as planned for 08/11/2025 on NASDAQ and shows 118,186,075 shares outstanding, allowing readers to see the absolute size of the notice.
The shares identified were acquired through various compensation programs and purchases between 2017 and 2025, mainly by restricted stock vesting and an employee stock purchase plan; specific lots and acquisition dates are listed. The filing reports Nothing to Report for securities sold during the past three months and includes the filer’s certification that no undisclosed material adverse information is known.
SunOpta (STKL) posted a solid turnaround in Q2-25. Revenue rose 12.9% YoY to $191.5 million, led by double-digit beverage, broth and fruit-snack volume gains. Gross margin expanded 230 bps to 14.8%, lifting gross profit to $28.4 million. Operating income jumped to $10.5 million from $2.0 million, and diluted EPS from continuing ops improved to $0.03 versus a $(0.04) loss.
For the first half, sales reached $393.1 million (+11.1%), net income $9.2 million (vs. a $(0.6) million loss) and diluted EPS $0.07. Operating cash flow was $17.8 million.
Balance sheet/liquidity: cash & equivalents $2.2 million plus $8.0 million restricted; long-term debt $233.1 million; leverage compliant with covenants. A $15 million trade loan, $85 million revolver ($40.7 million drawn) and $180 million term loan backstop liquidity. A $25 million share-repurchase plan began in Q2; 163,227 shares ($1.0 million) were bought, leaving $24 million authorized.
Key developments: 90 bp gross-margin drag from U.S. tariff timing; $6.7 million CBP duty accrual outstanding; receivables-sale program expanded to $42 million (sold balance $37.6 million). Company targets margin recovery via price pass-throughs, supply-chain efficiencies and increased plant utilization.
SunOpta Inc. (STKL) – Form 4 insider filing dated 07/29/2025
- Reporting person: Director Leslie Starr Keating
- Transaction date: 07/25/2025
- Common shares acquired: 3,683 shares, issued in lieu of cash director fees, at an accounting price of $6.64 per share (Code A).
- Restricted Stock Units (RSUs): 2,423 RSUs granted; each RSU converts 1-for-1 into common stock, no exercise price or expiration.
- Post-transaction ownership: 130,856 common shares (direct) and 39,740 RSUs (direct).
No dispositions were reported and the filing was made by a single reporting person. The equity was awarded as compensation rather than an open-market purchase, but it nonetheless increases the director’s direct economic alignment with shareholders.
SunOpta Inc. (STKL) Form 4 – Director share acquisition
On 07/25/2025, director Rebecca Fisher received additional equity compensation:
- Common shares: 1,916 shares acquired at a deemed price of $6.64 per share (transaction code A). Post-transaction direct ownership rises to 137,999 shares.
- Restricted Stock Units (RSUs): 2,423 RSUs awarded; total RSUs now 20,193. Each RSU converts 1-for-1 into common stock; the units have no expiration date.
The filing notes that the common shares were issued in lieu of cash compensation for board service, signalling an increased equity stake and alignment with shareholders. No dispositions were reported, and the director remains classified as an insider-director only.
FAQ
What is the current stock price of Sunopta (STKL)?
What is the market cap of Sunopta (STKL)?
